COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 1942: Articles 19411-19420  | Next

Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2
Palmer, M. V., Martins, M., Falkenberg, S., Buckley, A. C., Caserta, L. C., Mitchell, P. K., Cassmann, E., Rollins, A., Zylich, N. C., Renshaw, R. W., Guarino, C., Wagner, B., Lager, K., Diel, D. G.
10.1101/2021.01.13.426628 — Posted: 2021-01-14 Discussion: Offsite
A highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative elicits high titers of neutralizing antibodies
Malladi, S. K., Patel, U. R., Singh, R., Pandey, S., Kumar, S., Gayathri, S., Kalita, P., Pramanick, I., Reddy, P., Girish, N., Upadhyaya, A., Khan, M. S., Bhat, M., Mani, S., Bhattacharyya, S., Siddiqui, S., Tyagi, A., Jha, S., Pandey, R., Dutta, S., Ringe, R. P., Varadarajan, R.
10.1101/2021.01.13.426626 — Posted: 2021-01-14
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, M., De Marco, A., Lempp, F., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., Zepeda, S., di Iulio, J., Bowen, J. E., Montiel-Ruiz, M., Zhou, J., Rosen, L., Bianchi, S., Guarino, B., Silacci Fregni, C., Abdelnabi, R., Foo, S.-Y. C., Rothlauf, P. W., Bloyet, L.-M., Benigni, F., Cameroni, E., Neyts, J., Riva, A., Snell, G., Telenti, A., Whelan, S. P., Virgin, H. W., Corti, D., Pizzuto, M. S., Veesler, D.
10.1101/2021.01.14.426475 — Posted: 2021-01-14 Discussion: Onsite
Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms
de Rooij, M. M. T., Hakze-Van der Honing, R., Hulst, M., Harders, F., Engelsma, M., van de Hoef, W., Meliefste, K., Nieuwenweg, S., Oude Munnink, B., van Schothorst, I., Sikkema, R., van der Spek, A., Spierenburg, M., Spithoven, J., Bouwstra, R., Molenaar, R.-J., Koopmans, M., Stegeman, A., Van der Poel, W. H. M., Smit, L. A. M.
10.1101/2021.01.06.20248760 — Posted: 2021-01-14
Magnitude, change over time, demographic characteristics and geographic distribution of excess deaths among nursing home residents during the first wave of COVID-19 in France: a nationwide cohort study
Canoui-Poitrine, F., Rachas, A., Thomas, M., Carcaillon-Bentata, L., Fontaine, R., Gavazzi, G., Laurent, M., Robine, J.-M.
10.1101/2021.01.09.20248472 — Posted: 2021-01-14
Modeling the COVID-19 transmission in Italy: The roles of asymptomatic cases, social distancing, and lockdowns
Khairulbahri, M.
10.1101/2021.01.08.21249273 — Posted: 2021-01-14
The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction
Bennett, T. D., Moffitt, R. A., Hajagos, J. G., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., DeWitt, P. E., Gabriel, D., Garibaldi, B. T., Girvin, A. T., Guinney, J., Hill, E. L., Hong, S. S., Jimenez, H., Kavuluru, R., Kostka, K., Lehmann, H. P., Levitt, E., Mallipattu, S. K., Manna, A., McMurry, J. A., Morris, M., Muschelli, J., Neumann, A. J., Palchuk, M. B., Pfaff, E. R., Qian, J., Qureshi, N., Russell, S., Spratt, H., Walden, A., Williams, A. E., Wooldridge, J. T., Yoo, Y. J., Zhang, X. T., Zhu, R. L., Austin, C. P., Saltz, J. H., Gersing, K.
10.1101/2021.01.12.21249511 — Posted: 2021-01-13
In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.
Bajrai, L. H., El-kafrawy, S. A., Alnahas, R. S., Azhar, E. I.
10.1101/2021.01.11.426295 — Posted: 2021-01-13
Targeting conserved viral virulence determinants by single domain antibodies to block SARS-CoV2 infectivity
Singh, S., Dahiya, S., Singh, Y. J., Beeton, K., Jain, A., Sarkar, R., Dubey, A., Tehseen, S. A., Sehrawat, S.
10.1101/2021.01.13.426537 — Posted: 2021-01-13
Using image-based haplotype alignments to map global adaptation of SARS-CoV-2
Ouellette, T. W., Shaw, J., Awadalla, P.
10.1101/2021.01.13.426571 — Posted: 2021-01-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).